Holdings of First Trust Health Care AlphaDEX Fund
ISIN US33734X1431
First Trust Exchange-Traded AlphaDEX Fund · Original filing · Compare with another fund · Report an error
- Net assets
- 874.2M $ including 874.2M $ in equities, 100.0 %
- Positions
- 76 in 1 countries
- Top ten
- 25.6 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Organon & Co | 2,527,212 | 33.5M $ | 3.83 % |
| 2 | Humana Inc | 109,132 | 25.8M $ | 2.95 % |
| 3 | Elevance Health Inc | 64,637 | 24.3M $ | 2.78 % |
| 4 | Molina Healthcare Inc | 113,564 | 22.1M $ | 2.53 % |
| 5 | Cigna Group/The | 70,938 | 20.6M $ | 2.36 % |
| 6 | Globus Medical Inc | 219,621 | 19.8M $ | 2.27 % |
| 7 | Exelixis Inc | 441,186 | 19.6M $ | 2.24 % |
| 8 | Biogen Inc | 103,216 | 19.5M $ | 2.23 % |
| 9 | Solventum Corp | 289,778 | 19.5M $ | 2.23 % |
| 10 | Incyte Corp | 201,047 | 19.2M $ | 2.19 % |
| 11 | DaVita Inc | 123,121 | 19.1M $ | 2.19 % |
| 12 | Bio-Rad Laboratories Inc | 67,883 | 19M $ | 2.18 % |
| 13 | Universal Health Services Inc | 105,730 | 17.8M $ | 2.04 % |
| 14 | HCA Healthcare Inc | 39,985 | 17.4M $ | 1.99 % |
| 15 | Regeneron Pharmaceuticals, Inc. | 24,491 | 17.3M $ | 1.98 % |
| 16 | Cardinal Health, Inc. | 89,549 | 17.3M $ | 1.98 % |
| 17 | Zimmer Biomet Holdings Inc | 209,273 | 17.3M $ | 1.97 % |
| 18 | Chemed Corp | 40,076 | 17M $ | 1.95 % |
| 19 | Encompass Health Corp | 156,498 | 15.6M $ | 1.79 % |
| 20 | Masimo Corp | 85,107 | 15.2M $ | 1.74 % |
| 21 | Ionis Pharmaceuticals Inc | 201,598 | 15.1M $ | 1.72 % |
| 22 | Penumbra Inc | 46,100 | 15.1M $ | 1.72 % |
| 23 | Amgen Inc | 43,025 | 14.9M $ | 1.70 % |
| 24 | United Therapeutics Corp | 25,529 | 14.6M $ | 1.67 % |
| 25 | Pfizer Inc | 539,103 | 14.4M $ | 1.65 % |
| 26 | Becton Dickinson & Co | 96,279 | 14.3M $ | 1.64 % |
| 27 | Tenet Healthcare Corp | 80,219 | 14.2M $ | 1.63 % |
| 28 | Merck & Co Inc | 125,846 | 13.7M $ | 1.57 % |
| 29 | QIAGEN NV | 378,072 | 13.1M $ | 1.50 % |
| 30 | Insmed Inc | 92,576 | 12.6M $ | 1.44 % |
| 31 | Certara Inc | 1,991,842 | 12.2M $ | 1.40 % |
| 32 | Natera Inc | 56,770 | 11.7M $ | 1.34 % |
| 33 | Illumina Inc | 92,110 | 11.7M $ | 1.34 % |
| 34 | Henry Schein Inc | 154,050 | 11.5M $ | 1.31 % |
| 35 | Bristol-Myers Squibb Co | 187,197 | 11.3M $ | 1.30 % |
| 36 | Quest Diagnostics Inc | 57,932 | 11.3M $ | 1.29 % |
| 37 | Revvity Inc | 129,591 | 11.2M $ | 1.28 % |
| 38 | STERIS PLC | 51,343 | 11.1M $ | 1.27 % |
| 39 | Labcorp Holdings Inc | 42,553 | 10.9M $ | 1.25 % |
| 40 | Sarepta Therapeutics Inc | 521,760 | 10.9M $ | 1.25 % |
| 41 | ResMed Inc | 50,577 | 10.8M $ | 1.24 % |
| 42 | Gilead Sciences Inc | 81,464 | 10.7M $ | 1.22 % |
| 43 | Medtronic PLC | 131,027 | 10.6M $ | 1.21 % |
| 44 | UnitedHealth Group Inc | 27,972 | 10.4M $ | 1.19 % |
| 45 | Cooper Cos Inc/The | 158,790 | 10M $ | 1.14 % |
| 46 | GE HealthCare Technologies Inc | 159,504 | 9.7M $ | 1.11 % |
| 47 | Waters Corp | 25,416 | 7.9M $ | 0.90 % |
| 48 | Align Technology Inc | 44,152 | 7.8M $ | 0.89 % |
| 49 | Eli Lilly & Co | 8,229 | 7.7M $ | 0.88 % |
| 50 | Agilent Technologies Inc | 66,406 | 7.7M $ | 0.88 % |
| 51 | Neurocrine Biosciences Inc | 57,454 | 7.6M $ | 0.87 % |
| 52 | Medline Inc | 170,089 | 7.6M $ | 0.87 % |
| 53 | Halozyme Therapeutics Inc | 117,113 | 7.5M $ | 0.85 % |
| 54 | Thermo Fisher Scientific Inc | 15,398 | 7.4M $ | 0.84 % |
| 55 | Zoetis Inc | 64,030 | 7.4M $ | 0.84 % |
| 56 | BioMarin Pharmaceutical Inc | 133,988 | 7.2M $ | 0.83 % |
| 57 | Johnson & Johnson | 30,965 | 7.1M $ | 0.81 % |
| 58 | IQVIA Holdings Inc | 44,382 | 7M $ | 0.80 % |
| 59 | Abbott Laboratories | 73,722 | 6.7M $ | 0.77 % |
| 60 | Medpace Holdings Inc | 15,763 | 6.6M $ | 0.75 % |
| 61 | West Pharmaceutical Services Inc | 14,155 | 4.2M $ | 0.48 % |
| 62 | Sotera Health Co | 247,418 | 3.8M $ | 0.44 % |
| 63 | Royalty Pharma PLC | 73,962 | 3.7M $ | 0.42 % |
| 64 | Edwards Lifesciences Corp | 44,305 | 3.7M $ | 0.42 % |
| 65 | Envista Holdings Corp | 139,849 | 3.6M $ | 0.42 % |
| 66 | IDEXX Laboratories Inc | 6,315 | 3.5M $ | 0.41 % |
| 67 | Intuitive Surgical Inc | 7,697 | 3.5M $ | 0.40 % |
| 68 | AbbVie Inc | 16,313 | 3.4M $ | 0.39 % |
| 69 | Stryker Corp | 10,798 | 3.4M $ | 0.39 % |
| 70 | Viking Therapeutics Inc | 109,034 | 3.4M $ | 0.39 % |
| 71 | Vertex Pharmaceuticals Inc | 7,945 | 3.4M $ | 0.39 % |
| 72 | Dexcom Inc | 56,496 | 3.4M $ | 0.38 % |
| 73 | Danaher Corp | 18,713 | 3.3M $ | 0.38 % |
| 74 | Alnylam Pharmaceuticals Inc | 10,723 | 3.3M $ | 0.38 % |
| 75 | Boston Scientific Corp | 56,542 | 3.3M $ | 0.37 % |
| 76 | Veeva Systems Inc | 20,198 | 3.2M $ | 0.36 % |
Sector breakdown
- Health care 55.8 %
- Technology 0.4 %
- Unattributed 43.8 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 76 | 874.2M $ | 100.00 % |
Cite this page
Titelia. "Holdings of First Trust Health Care AlphaDEX Fund". https://titelia.com/en/funds/S000017700